Midgard Science

Labs / CDMO: development & manufacturing

ScinoPharm Taiwan, Ltd.

Tainan, Taiwan · scinopharm.com

GLP · GMP

ScinoPharm Taiwan, Ltd. develops and manufactures high-barrier APIs and drug products, with integrated CDMO and CMC services for global pharmaceutical clients. The company is headquartered in Tainan, Taiwan, and also operates API manufacturing facilities in Taiwan and Changshu, China.

They take quote requests by email.

What they offer

  • API development and manufacturing

    Develops and manufactures high-potency APIs, including oncology, CNS, cardiovascular, orphan drug, small molecule, and peptide products.

  • Drug product development and manufacturing

    Develops and manufactures injectable drug products, including sterile and high-potency injectables.

  • CDMO services

    Provides end-to-end contract development and manufacturing from process development and clinical sample preparation to commercial-scale production.

  • CMC capabilities and support

    Offers one-stop CMC solutions including technical guidance, regulatory support, market authorization application, and post-launch process improvement.

  • Contract analytical testing services

    Provides cGMP-compliant analytical testing as part of its CDMO offering.

What they work on

Modalities
Small molecule, Peptide
Assays and studies
analytical testing, cGMP-compliant analytical testing, process hazard analysis, safety testing, toxicity prediction
Instruments and platforms
differential scanning calorimeters, reaction calorimeters, adiabatic calorimeters (PHI-TEC II), eQMS, Derek Nexus, Sarah Nexus for Windows, 10 m2 freeze-dryer (lyophilizer)
Scale and capacity
18 CGMP-compliant production lines, reactors ranging from 20 L to 10,000 L, batches from a few grams to metric ton scale, production capacity up to 200 kg per year, maximum capacity of 7,800 units per hour for 1 mL products, maximum batch size of approximately 19,000 units for 10R ISO vials
Therapeutic areas
oncology, hematology, central nervous system disorders, metabolic diseases, cardiovascular, orphan diseases
Type
CRDMO
Sites
Tainan, Taiwan · Changshu, China
Team
over 100 scientists and researchers
Quality
FDA (inspections, approval, and cGMP compliance) · EMA (approval and cGMP compliance) · PMDA (approval and cGMP compliance) · PIC/S GMP (manufacturing compliance) · ICH Q10 (quality management) · TFDA (requirements and inspections) · cGMP (manufacturing compliance) · ISO/IEC 27001:2022 (Information Security Management System (ISMS) Certification) · PSCI (passed audits by pharmaceutical partners) · Responsible Care® (environment, health, and safety initiative)
Serves
worldwide, U.S., Europe, over 100 countries
Founded
1997

Public records

FDA establishment
3002840477
FDA drug establishment
ScinoPharm Taiwan, Ltd. source
FDA drug establishment registration
3002840477 · ANALYSIS; API MANUFACTURE; MANUFACTURE; PACK; RELABEL; REPACK source

Similar labs. ARSI Canada Inc, Aurigene Pharmaceutical Services, CordenPharma, DSK InnoSciences

Found in a contract services directory. Listing built from scinopharm.com. Work here? Claim this listing.

ScinoPharm Taiwan, Ltd. · Midgard Science